netFormulary NHS
Nottinghamshire Area Prescribing Committee
Joint Formulary
 Search
 Formulary Chapter 11: Eye - Full Chapter
Chapter Links...
 Details...
11.99.99.99  Expand sub section  Miscellaneous
11.99.99.99  Expand sub section  Cytotoxics / wound healing modulators
11.99.99.99  Expand sub section  Fibrinolytic drugs
11.99.99.99  Expand sub section  Glues - ocular
11.99.99.99  Expand sub section  Immunosuppressants to top
Ciclosporin
(Eye)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

Oily eye drops 2% (Unlicensed Product), formulated in arachis oil. Avoid in peanut allergy
Eye ointment 0.2% (Unlicensed Vetinary Product, Optimmune®)used only as alternative when 2% drops unavailable. Preservative free but contains lanolin

  • both specialist use at NUH only
  • 2% eye ointment = non-formulary
  • 0.05% preservative free = non-formulary
  • 0.06% preservative free multidose = non-formulary
  • Neoral® for Uveitis Red Traffic Light
  • Ikervis® 0.1% eye drops single use- Subject of NICE TA369 - see link below for information sheet
  • Verkazia® 0.1% eye drops for vernal keratoconjuntivitis licensed for children (over 4years old) and adolecents (not adults)  = - see link below for information sheet
 
Link  Ciclosporin eye drops information sheet - Ikarvis
Link  Ciclosporin eye drops information sheet - Verkazia
Link  NICE TA369 - Ciclosporin for treating eye disease that has not improved despite treatment with artificial tears
   
Cytotoxic Drug Methotrexate
(Eye)
View adult BNF View SPC online View childrens BNF
Formulary
Red
Homecare
  • For use in Uveitis
  • Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
 
   
11.99.99.99  Expand sub section  Treatment of burns
11.99.99.99  Expand sub section  Visco-elastics
11.99.99.99  Expand sub section  Other
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Grey

Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting.
Grey / Non-Formulary (no formal assessment): APC has not formally reviewed this medicine or indication because it had never been requested for formulary inclusion. Often used for drugs new to market.
  

Red

Medicines which should normally be prescribed by specialists only. eg hospital only.
For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.
  

Amber 1

Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised.
Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC.
  

Amber 2

Medicines suitable to be prescribed in primary care / general practice after specialist* recommendation or initiation.
A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust DTCs and approved by the Nottinghamshire APC.
*Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice
  

Amber 3

Primary care/ non specialist may initiate as per APC guideline.
The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC.
  

Green

Medicines suitable for routine use within primary care.
Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.   

OTC

  

netFormulary